We found that treatment of gliomas with imipramine but not antiangiogenic agents downregulated an M2-like program, as assessed in bulk tumors and specifically in the total macrophage population in LVRshp53 and PDG models (Figures 4A and 4B, and S5A–S5C). The gene discussed is PHGDH; the disease is central nervous system cancer.